A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group.

Source:http://linkedlifedata.com/resource/pubmed/id/8385564

Cancer 1993 May 1 71 9 2723-6

Download in:

View as

Triples

General Info

PMID
8385564